Klinische FragestellungAutoimmun-LymphoProliferatives Syndrom, ALPS; Differentialdiagnose
Zusammenfassung
Kurzinformation
Ein umfassendes differentialdiagnostisches panel für Autoimmun-LymphoProliferatives Syndrom mit 5 Leitlinien-kuratierten Genen sowie insgesamt 28 kuratierten Genen
ID
AP9281
Anzahl Gene
1
Akkreditierte Untersuchung
Untersuchte Sequenzlänge
0,0 kb (Core-/Core-canditate-Gene)
0,6 kb (Erweitertes Panel: inkl. additional genes)
0,6 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Untersuchungsmaterial
- EDTA-Blut (3-5 ml)
Diagnostische Hinweise
NGS +
Genpanel
Ausgewählte Gene
Name | Exon-Länge (bp) | OMIM-G | Referenz-Seq. | Erbgang |
---|---|---|---|---|
KRAS | 567 | NM_004985.5 | AD |
Infos zur Erkrankung
Synonyme
- Alias: ALPS
- Alias: Canale-Smith-Syndrom
- Alias: FAS-Mangel
- Allelic: Cardiofaciocutaneous syndrome 2 (KRAS)
- Allelic: Celiac disease, susceptibility to, 3 (CTLA4)
- Allelic: Diabetes mellitus, insulin-dependent, 12 (CTLA4)
- Allelic: Hashimoto thyroiditis (CTLA4)
- Allelic: Hyper-IgE recurrent infection syndrome (STAT3)
- Allelic: Immunoglobulin A deficiency 2 (TNFRSF13B)
- Allelic: Neutropenia, severe congenital, XL (WAS)
- Allelic: Noonan syndrome 3 (KRAS)
- Allelic: Systemic lupus erythematosus, susceptibility to (CTLA4)
- Allelic: Systemic lupus erythematosus, susceptibility to, 9 (CR2)
- Allelic: Thrombocytopenia, XL (WAS)
- Allelic: Thrombocytopenia, XL, intermittent (WAS)
- Autoimmune disease, multisystem, infantile-onset, 1 (STAT3)
- Autoimmune lymphoproliferative syndrome, type IA (FAS)
- Autoimmune lymphoproliferative syndrome, type IB (FASLG)
- Autoimmune lymphoproliferative syndrome, type II (CASP10)
- Autoimmune lymphoproliferative syndrome, type III (PRKCD)
- Caspase 8 lymphadenopathy syndrome (CASP8)
- Immune dysregulation with autoimmunity, immunodeficiency, lymphoproliferation (CTLA4)
- Immunodeficiency 90 with encephalopathy, functional hyposplenia, hepatic dysfunction (FADD)
- Immunodeficiency with hyper IgM, type 5 (UNG)
- Immunodeficiency with hyper-IgM, type 2 (AICDA)
- Immunodeficiency with hyper-IgM, type 3 (CD40)
- Immunodeficiency, XL, with hyper-IgM (CD40LG)
- Immunodeficiency, common variable, 1 (ICOS)
- Immunodeficiency, common variable, 10 (NFKB2)
- Immunodeficiency, common variable, 11 (IL21)
- Immunodeficiency, common variable, 12 (NFKB1)
- Immunodeficiency, common variable, 13 (IKZF1)
- Immunodeficiency, common variable, 14 (IRF2BP2)
- Immunodeficiency, common variable, 2 (TNFRSF13B)
- Immunodeficiency, common variable, 3 (CD19)
- Immunodeficiency, common variable, 4 (TNFRSF13C)
- Immunodeficiency, common variable, 5 (MS4A1)
- Immunodeficiency, common variable, 6 (CD81)
- Immunodeficiency, common variable, 7 (CR2)
- Immunodeficiency, common variable, 8, with autoimmunity (LRBA)
- Lymphoproliferative syndrome, XL, 1 (SH2D1A)
- RAS-associated autoimmune leukoproliferative disorder (KRAS)
- Wiskott-Aldrich syndrome (WAS)
Erbgänge, Vererbungsmuster etc.
- AD
OMIM-Ps
- Multiple OMIM-Ps
ICD10 Code
Bioinformatik und klinische Interpretation
Kein Text hinterlegt